Predicting infection in belly fluid from cirrhosis
Part of Digestive system clinical trials.
This study looks for signs that predict a bacterial infection in the belly fluid of people with liver cirrhosis. It aims to catch infection early and improve treatment for patients with ascites.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis and moderate to large belly fluid seen on ultrasound.
- You are between 18 and 70 years old.
- You are not pregnant and you haven't had belly surgery in the last 12 weeks.
- You have not taken antibiotics for at least 4 weeks, and you don't have other infections or cancers.
- You do not have conditions like severe high blood pressure, diabetes, or high cholesterol that could affect your platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to detect bacteria in the fluid in your belly (ascites) to see if it can quickly diagnose a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis. If you have cirrhosis and ascites, this trial may help improve how fast infections are found.
This trial tests whether draining infected belly fluid early can help people with cirrhosis and a type of infection called SBP (spontaneous bacterial peritonitis). If you have cirrhosis and your belly fluid is infected, this study may show if early drainage improves recovery.
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
This study looks at bacterial infections in people with cirrhosis to understand which antibiotics still work. The goal is to improve treatment for future patients with liver disease.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study develops a tool to predict which liver transplant patients might develop infections after surgery. By identifying high-risk patients early, doctors could provide extra monitoring or preventive care to improve outcomes.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.